This inventor holds 9 USPTO granted patents and 15 published patent applications and 7 EPO patents. Top assignees: Advanced Accelerator Applications Sa, Advanced Accelerator Applications (Italy) S.r.l., Advanced Accelerator Applications. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 14 
2 out of 2 
1 out of 7 Years Active: 2020-2025
Title: Inventor Spotlight: Francesco De Palo
Introduction
Francesco De Palo is a distinguished inventor based in Ivrea, Italy. With a total of seven patents to his name, he has made significant contributions in the field of radionuclide complex solutions. His work not only showcases his innovative prowess but also emphasizes the potential for advancements in diagnostic and therapeutic applications.
Latest Patents
One of Francesco's most notable recent inventions is a stable, concentrated radionuclide complex solution. This groundbreaking technology relates to high-concentration solutions that exhibit exceptional chemical stability. Such stability is crucial for their application as drug products in both diagnostic and therapeutic settings. The invention leverages at least one stabilizer to combat radiolytic degradation. An innovative aspect of his solution is the use of two stabilizers introduced at different stages during the manufacturing process, which has proven to enhance the product's overall performance.
Career Highlights
Francesco De Palo has built his career working with notable organizations, including Advanced Accelerator Applications and Advanced Accelerator Applications (Italy) S.r.l. His experience in these companies has enabled him to develop and refine his inventions, positioning him as a prominent figure in the field of radionuclide research.
Collaborations
Throughout his career, Francesco has collaborated with talented colleagues such as Lorenza Fugazza and Donato Barbato. These partnerships have facilitated a rich exchange of ideas and technical expertise, ultimately driving forward the innovation process within their field.
Conclusion
Francesco De Palo stands out as a notable inventor whose work has the potential to transform medical diagnostics and therapies. With a strong foundation of patents and collaborative efforts with esteemed colleagues, he continues to contribute to the advancement of radionuclide technology, paving the way for significant future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile